Xencor, Inc. (NASDAQ:XNCR), a clinical-stage biopharmaceutical company developing engineered antibodies for the treatment of ...

In letters posted on Truth Social, Trump demanded that drugmakers offer their medications at the same prices paid abroad.

President Trump on Thursday sent letters to 17 of the world’s largest drug companies, telling them to take more steps to ...

Trump signed an Executive Order May 12 directing the administration to take action to bring drug prices charged in the U.S.

Consumer discretionary stocks are at the forefront of the retail and leisure sectors, driven by robust consumer spending ...

This was the stock's third consecutive day of losses.

Amgen (NASDAQ:AMGN) today announced that it will report its second quarter 2025 financial results on Tuesday, August 5, 2025, after the close of the U.S. financial markets. The announcement will be ...

President Donald Trump is ratcheting up the pressure on major drugmakers to bring their US prices in line with the far lower ...

In 17 identical letters posted to his Truth Social account, the president said companies must lower their prices or the ...

Trump demanded that pharmaceutical companies lower their drug prices. But it's unclear how the government may enforce the ...

Kissei Pharmaceutical is paying Viridian Therapeutics $70 million upfront for Japanese rights to a pair of thyroid eye ...

With a $5 billion investment, the 3,000-employee campus leads biomanufacturing innovation while embracing AI, education and ...